See also this year's filing and all EDGAR filings for this company.
PDF Report 0001005201_2016_Assertio_Therapeutics_Inc.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001005201, Assertio Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 308,972,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 1,008,994,000 |
| 2 | PropertyPlantAndEquipmentNet | 14,794,000 |
| 3 | remainder_Assets | 30,672,000 |
| 4 | LiabilitiesCurrent | 219,632,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 248,533,124 |
| 9 | ResearchAndDevelopmentExpense | 17,513,408 |
| 10 | remainder_Expenses | 124,900,128 |
| 11 | remainder_Revenues | 346,985,247 |
| 12 | remainder_NetIncome | -318,447,558 |
| 13 | remainder_ComprehensiveNetIncome | -21,300 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 1,363,432,000 |
| 1 | Liabilities | 219,632,000 |
| 2 | Expenses | 390,946,660 |
| 3 | Revenues | 346,985,247 |
| 4 | StockholdersEquity | 1,143,800,000 |
| 5 | NetIncome | -362,408,971 |
| 6 | ComprehensiveNetIncome | -362,419,621 |
| 7 | BaseVar | 1,319,732,382 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.69 |
| 9 | EconomicCapitalRatio | 3.48 |
Edgar->Model Mapping
Feature Distribution
Change over Time
